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 Research faculty who procure extramural funding need departmental support to 
satisfy the demands of conducting clinical research trials. The growing complexities, 
regulations, and ethical requirements of clinical research can be arduous. This may 
discourage faculty who have minimal protected time for research due to clinical and/or 
training obligations. Often research faculty are unaware of the support a highly qualified 
Clinical Research Coordinator (CRC) can provide. Retaining highly qualified CRCs has 
become difficult as the role has become more extensive and often leads to burnout. 
 This project involves the development of a guide to assist Principal Investigators 
in managing and supporting Clinical Research Coordinators (CRCs). The guide is an easy 
to follow, comprehensive resource that provides information on hiring, training, 
workload management, and helpful tips on professional development and performance 
evaluation, based on research and the author’s experience as a CRC and assistant director 
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Clinical Research. Research involving human subjects or material of human origins such 
as tissues, specimens, and data. 
 
Clinical Trial. A research study in which one or more human subjects are prospectively 
assigned to one or more interventions (which may include placebo or other control) to 
evaluate the effects of those interventions on health-related biomedical or behavioral 
outcomes.1 
 
High Impact Communication. Clearly and succinctly conveying information and ideas 
to individuals and groups in a variety of situations; communicating in a focused and 
compelling way that drives others’ thoughts and actions. 
 
Emotional Intelligence. Establishing and sustaining trusting relationships by accurately 
perceiving and interpreting one’s own and others’ emotions and behavior in the context 
of the political environment; leveraging insights to effectively manage one’s responses 
and reactions. 
 
Good Clinical Practice. A standard for the design, conduct, performance, monitoring, 
auditing, recording, analyses, and reporting of clinical trials that assures that the data and 
reported results are credible, accurate and that the rights, integrity, and confidentiality of 
trial subjects are protected.2  
 
SMART Objectives. S.M.A.R.T. is an acronym used to guide the development of 
measurable goals. Each objective should be: Specific, Measurable, Achievable, Relevant, 
and Time oriented. 
 
Translational Research. The process of turning observations in the laboratory, clinic, 




                                               
1 “NIH, National Institute of Allergy & Infectious Disease (NIAID).” Rules and Policies for Clinical 
Research. Last modified July 18, 2018.https://www.niaid.nih.gov/research/clinical-research 






ACRP  Association of Clinical Research Professionals 
BCM  Baylor College of Medicine 
CRC  Clinical Research Coordinators 
CTU  Clinical Trials Unit 
GCP  Good Clinical Practice 
IAR  Immunology Allergy & Retrovirology 
IRB  Investigative Review Board 
MGMA  Medical Group Management Association 
NCRR  National Center for Research Resources 
NCURA National Council of University Research Administrators 
NIH  National Institutes of Health 
PHACS Pediatric HIV/AIDS Cohort Study 
PI  Principal Investigator 






















Chapter 1. Introduction 
1.1. Background 
      The Departments of Immunology Allergy Retrovirology (IAR) and 
Rheumatology, at Texas Children’s Hospital, are affiliated with Baylor College of 
Medicine (BCM), Department of Pediatrics. In 2012, several clinical research programs 
were initiated in the areas of food allergy, immunogenetics, HIV/AIDS, primary immune 
deficiency disorders, and rheumatologic disorders. The two departments started with four 
Clinical Research Coordinators (CRCs) but quickly expanded to 16 with one Assistant 
Director of Research providing oversight. 
      The coordinators worked directly with faculty Principal Investigators (PIs) who 
were new to sponsored research and/or unfamiliar with managing and supporting CRCs. 
Several of the PIs attempted to conduct trials without a coordinator or by utilizing the 
institution’s central resource that was either too costly or unable to meet projected 
timelines. There was also the concern of high CRC turnover, within a national network, 
affiliated with the HIV/AIDS program. 
          For these reasons, this author decided that developing a CRC management guide 
would be a good resource for faculty PIs in the IAR and Rheumatology departments. The 
guide would also be a useful tool for other departments within Texas Children’s Hospital, 
Baylor College of Medicine, and affiliated networks. In addition to training and 
orientation, this guide would provide helpful information regarding talent selection, 
orientation, retention, workload management, evaluation, and transition. 
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1.2. Statement of the Problem 
PIs are not always familiar with the training and development required for a CRC 
to successfully implement clinical research trials. Once the CRC is fully trained it is 
another matter to make sure there is a balance between meeting enrollment targets and 
satisfactory performance.  
      There is also a need for PIs to understand the kind of support the CRCs need in to 
meet the study responsibilities that are placed on them. As protocols are becoming more 
complex and the roles of the CRCs are more extensive, the added burden may negatively 
affect their performance. Adequate training and sustained support are important to abate 
mistakes, burnout, and CRC turnover.      
1.3. Project Question 
      The main question is how can the researcher of this project bridge the gap 
between the knowledge and understanding a PI needs to successfully manage and support 
CRCs who play a pivotal role in the overall success of study conduct, study outcomes, 
research subject safety, and data integrity. 
1.4. Project Objectives 
     The primary objective of this project is to create a resource for PIs that guides in 
the successful management and support of CRCs from the time they are hired to the time 
they transition to new employment opportunities or retire. The secondary objective is to 
ensure PIs in the IAR and Rheumatology departments can continue to procure research 
funding by showing sponsors they can conduct quality research, on time, and reach 
enrollment targets. According to Holly Zink, a measure or important predictor of faculty 
research productivity are individual attributes combined with institutional attributes, such 
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as support systems and administrative assistance.3 The combination of a faculty 
researcher with attributes such as emotional intelligence and high impact communication 
skills along with a highly qualified and motivated CRC are paramount. 
Also, a successful research program could elevate the IAR and Rheumatology 
departments’ reputation at the community, national, regional, and international levels.4 
This would increase income-generating capacities by attracting future faculty with a 
strong interest in medical research, ensuring the future success of the departments.5 
1.5. Significance 
       The author of this project understands the stress CRCs face between expanding 
workloads and the continued effort to meet the demands of the PI(s).  The CRC may not 
always have the confidence to express the need for more help and/or support. Although 
the CRC may find the work fulfilling both professionally and personally, the thought of 
having to face the consequences of making an error may cause the CRC to leave the 
position. To find and properly train a replacement, would cost the department valuable 
time and money. 
 According to the Medical Group Management Association (MGMA), 
“The cost of replacing an employee is 50% to 150% of the annual salary for that position, 
therefore, it can cost a medical practice from $25,000 to $75,000 to replace an employee 
                                               
3 Holly R. Zink. 2018. “Department-Centered Research Administration: Building a General Research 
Administrative Support Program (GRASP).” Research Management Review 23, no.1. 
https://www.ncura.edu/portals/0/docs/rmr/2018/v23_n_1_zink.pdf 




with a yearly salary of $50,000.” 6 This includes the cost of recruiting, hiring, training, 
and productivity lost during the new employee’s first 6 months.7  
      BCM research faculty are under pressure to procure funding as the institution 
does not look favorably upon unfunded research. With limited protected research time, 
faculty PIs must rely on the competence of highly qualified CRCs who can perform 
clinical research in compliance with regulatory guidelines and Good Clinical Practice 
(GCP). By having a management guide, the hope is the department will retain competent, 
motivated, and productive CRCs. 
1.6. Exclusions and Limitations 
The guide is not all-inclusive of CRC orientation requirements but it provides 
references to many other tools and manuals that are available within the department, 






                                               





Chapter 2. Review of Literature 
2.1. Overview of Literature Review 
     The literature search was related to the management and support of CRCs using 
PubMed, Society of Clinical Research Associates (SOCRA), National Council of 
University Research Administrators (NCURA), and Google search engine. Attempts 
were made to locate similar examples of CRC management guides to provide a basis for 
this project. There were many articles, tools, and guides that provided information on 
CRC orientation. However, this author could not find anything similar to a guide that 
goes beyond the orientation phase of CRC support and development. Presentations from 
coordinators of the Pediatric HIV/AIDS Cohort Study (PHACS) network meetings have 
also provided information in developing content for the guide. 
2.2. Details of Review 
 2.2.1. Journal Articles 
 The researcher was able to locate studies and journal articles about CRC hiring 
practices, job satisfaction as well as roles and responsibilities. The Research Coordinator 
Taskforce, implemented by the National Institutes of Health (NIH) National Center for 
Research Resources (NCRR) conducted two surveys. The results are summarized in “The 
Critical Need for Academic Health Centers to Assess the Training, Support, and Career 
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Development Requirements of Clinical Research Coordinators: Recommendations from 
the Clinical and Translational Science Award Research Coordinator Taskforce.”8  
The survey on hiring practices shows that approximately 60% of CRC positions 
take an average of 3 - 6 months to fill.9 The majority of CRCs are hired and managed by 
individual principal investigators or departments. The article also shows that 80% of the 
coordinators surveyed were scheduled to work 40-hour weeks. However, 42% reported 
working more than 40 hours, some as high as 50 hours per week. 10  
 The total number of studies supported by the 1,574 CRC respondents was 9,842, 
with an individual coordinator supporting from 1 to 85 studies for 1 to 50 investigators. 
Regarding CRC satisfaction, more than 75% of CRCs described their work as both 
professionally and personally fulfilling, and 85% believe their job is an important aspect 
of the overall mission of their institution.11 However, being overworked was reported as 
one of the top negative aspects of their job, and 15% listed burnout as a reason for 
leaving their job, while 17% reported a lack of career advancement.12 
Several studies were cited and/or conducted by the authors of “The Invisible Hand 
in Clinical Research: The Study Coordinator’s Critical Role in Human Subjects 
Protection.”13 The article spoke of studies that show adding a coordinator to a research 
                                               
8 Lisa Speicher et al, “The Critical Need for Academic Health Centers to Assess the Training, Support, and 
Career Development Requirements of Clinical Research Coordinators: Recommendations from the Clinical 
and Translational Science Award Research Coordinator Taskforce,” Clinical Translational Science 5, no. 6 





13 Arlene Davis et al, “The Invisible Hand in Clinical Research: The Study Coordinator\s Critical Role in 
Human Subjects Protection,” Journal of Law, Medicine & Ethics 30 (2002): 411-419,  
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team significantly improves subject recruitment numbers, enhances subject retention, and 
increases general study efficiency.  
The authors conducted a focus group interview study to determine to what extent 
coordinators shape the ethical conduct of clinical research and how their workload affects 
the protection of subjects. Seven 90-minute focus groups with a total of 45 participants 
were conducted. The study concluded that “the study coordinator is the person with 
whom study participants interact the most, and the one most able to identify their needs 
and employ necessary procedural safeguards.14  
The authors described the CRC as central to the PI, Investigational Review 
Boards (IRBs), study monitors, study staff, referral networks, subjects/families, 
clinics/departments, and other supervisors.15 The CRC requires multiple skill sets that 
include the ability to advance research goals using a variety of research-related skills; 
psychosocial skills; communication skills; and complex organizational skills including 
managing the protocol, functioning as a team member, and coordinating outside units.16 
2.3. Applicability of Literature Review 
 The literature review helps to establish the relevance of hiring and retaining a 
highly-skilled CRC. It also shows the potential for turnover when the needs of the CRC 
are not met or understood.  
 
  
                                               





Chapter 3: Need Assessment 
 
3.1. Establishing the Need for a Guide 
 The author of this project has the background of a Clinical Research Nurse 
Coordinator and successfully managing a Clinical Trials Unit (CTU) for a combination of 
25 years. Now that this author has been promoted to Assistant Director of Research, the 
coordinators must be managed by the PIs as is the case in most of the departments within 
Texas Children’s Hospital and Baylor College of Medicine. The guide would be shared 
with PIs within the department and other departments within the institution. 
 The author of this project has been asked to guide other CTU’s within an 
affiliated network, National Institutes of Health (NIH) sponsored Pediatric HIV/AIDS 
Cohort Study (PHACS)17. The CRC management and support guidance is provided on 
monthly leadership conference calls and annual network meetings held in Bethesda, 
Maryland. The guide would be given to the leadership of this network as a tool for 
current and future PIs and/or senior CRCs. 
3.2. Metrics 
 There were no specific metrics used to evaluate the need for developing a guide. 
Instead, this project is a compilation of both the author’s experience and other resources 
to guide in hiring, orienting, managing, evaluating, and transitioning CRCs. 
                                               
17 “Pediatric HIV/AIDS Cohort Study (PHACS),” National Institute of Child Health and Human 





The Department Chief,  Director of Clinical and Translational Research, PI for the 
NIH sponsored HIV/AIDS research, PI for the Childhood Arthritis Rheumatology 
Research Alliance and the Practice Administrator are in support of and have all agreed 
that the guide would be a valuable resource provided by this author. 
3.4. Committee 
 The main point of contact throughout the project was the Director of Clinical and 
Translational Research for the Food Allergy Program and the mentor for this project. The 
senior CRC for the Food Allergy research was a point of contact as well. In-person 
meetings were held along with email correspondence. 
 3.4.1 Role of Committee in Project 
The role of the committee was to review the Guide and give feedback on the 
relevance of the material provided in each chapter based on the needs of the departments, 
then give final approval.  Also, this committee will play a large role in the promotion and 
distribution of this guide to the faculty PI within the department. 




Chapter 4: Project Description 
4.1. Project Elements 
 This project involves the creation of a guide with a compilation of information, 
methods, and tools, created by this author, that new PI’s and senior CRCs may use to 
hire, train, develop, and retain highly qualified CRCs. This guide provides information 
from the Texas Children’s Hospital (TCH) intranet, Baylor College of Medicine (BCM) 
research resources, orientation methods, and tools from other institutions and articles.  
 Navigating the TCH and BCM intranet for information can be time-consuming 
and daunting. Whereas, this guide will be an easily accessible resource within the IAR 
and Rheumatology Departments. It provides the main guidance that is essential to 




Chapter 5: Methodology 
5.1. Methodology Overview 
 The approach to gathering content for the guide was to perform extensive research 
into existing policies/procedures, peer-reviewed articles, in addition to the author’s 25 
years of experience as a CRC and Clinical Trials Unit (CTU) coordinator.  Articles on 
effective management and building a team culture provided great insight regarding 
retention as CRC turnover can be very costly and disruptive to the research program. 
Peer-reviewed methods and validated tools provided by articles from the Society 
of Clinical Research Associates (SoCRA) and the National Cancer Institute (NCI) were 
thoroughly reviewed and deemed useful for managing CRC workloads. References to 
other resources such as departmental SOPs, BCM online training, and IRB policies were 
compiled for the convenience of having all the information in one document. 
5.2 Project Design and Discussion 
 There are six essential elements in the project design: CRC Talent Selection, the 
orientation of the CRC once hired, CRC retention, managing the CRC workload, 
evaluation, and feedback of the CRC’s performance, and transitioning the CRCs project 
to another research team member in the event of their resignation and/or retirement. 
These six elements cover the spectrum of the CRC’s experience from the beginning to the 
end of service in the IAR and Rheumatology Departments. 
12 
 
5.2.1 Talent Selection 
 The Texas Children’s Hospital (TCH), Human Resources Department, provides 
Success Profiles which are a collection of competencies needed for an employee to 
effectively perform his/her job. This author selected the major competencies that best fit 
the role of a CRC and incorporated them in the guide. These competencies can be used in 
the talent selection/hiring process and to provide performance expectations upfront as 
part of orientation.  
 A CRC must be able to connect with study participants, carry out key clinical, 
administrative, regulatory responsibilities, and be committed to the research project. 
Therefore, the following competencies were chosen: Interpersonal Sensitivity, Decision 
Making/Problem Solving, Planning and Organizing, Technical/Professional Knowledge 
and Skills, Work Standards, and Adaptability. 
5.2.2 Orientation of the CRC Once Hired 
 The CRC orientation in this Guide is based on the National Institute of Allergy 
and Infectious Diseases (NIAID) rules and policies for clinical research.18 The NIAID 
has developed research standards regarding Human Subject Protection (HSP) and Good 
Clinical Practice (GCP) to maximize and harmonize the quality of clinical research. The 
four NIAID standards include Clinical research development, review, conduct and 
oversight; Clinical research management; Training and education; and Quality assurance 
and quality control.19    
                                               
18 “NIH, National Institute of Allergy & Infectious Disease (NIAID).” Rules and Policies for Clinical 




 A list of required research ethics training includes the Department of Health and 
Human Services (DHHS) Code of Federal Regulations (CFR) 45 CFR part 46, and the 
International Council for Harmonisation (ICH) Good Clinical Practice (GCP). BCM 
requires the CRC to complete an online course in Researcher Conflict of Interest (COI), 
and Health Information Privacy and Security (HIPS).   
 The IAR and Rheumatology Department-required BCM training include an 
Informed Consent Workshop, a Research Investigator Workshop, Lab Safety Training, 
and the International Air Transportation Association (IATA) Biological Shipping Online 
Training. The contact and registration information for each course is listed in the guide. 
 Protocol specific training includes a training tool, created by the author, with a 
checklist for the CRC and PI to follow. The CRC will review the protocol materials and 
attend sponsor training. The PI, or preceptor designated by the PI, will assess the CRC‘s 
understanding of critical Protocol Elements and Informed Consent. Then the CRC will 
meet with the Regulatory Coordinator to review and file compliance documentation. 
Once all items are checked off the PI will sign and date the checklist. 
  Out of all the orientation manuals reviewed by this author during the literature 
review, the Maine Medical Center Research Institute Orientation Manual for Clinical 
Research Coordinators provided the most detailed information.20 It provided details on 
competencies related to ethics, protocol feasibility, and collaboration with other 
departments, study initiation, informed consent, protocol implementation, investigational 
                                               
 20 “Orientation Manual for Clinical Research Coordinators. Maine Medical Center Research Institute.” 






drugs and/or devices, subject safety, financials, data entry, and study close-out. This 
author was able to enhance current orientation processes by incorporating essential 
details from the Maine Medical Manual but utilized it in a different format.  Instead of 
the PI and/or designee having to sign 14 different approval documents, a signature is only 
required on one form.    
5.2.3 Retention of the CRC  
 This guide contains invaluable information on methods used to reduce turn-over 
and retain highly qualified CRCs. This is especially important due to the extensive 
amount of time that it takes to train a CRC. By managing the workload, supporting 
professional development, and offering a work environment that provides work-life 
balance, job satisfaction is significantly improved. The guide gives information regarding 
professional development opportunities which would demonstrate an investment in the 
CRC’s career and highlight their value within the research program. Examples include 
memberships with and/or certifications from the National Council of University Research 
Administrators (NCURA), SoCRA, and the Association of Clinical Research 
Professionals. Based on this author’s literature review, flexible scheduling also promotes 
retention as it allows the CRC to schedule longer hours on some days and shorter hours 
on another to be able to take care of personal business, without having to use vacation 
pay.21 There are suggestions on creative performance rewards such as a gift card for the 
                                               
 21 “Effective Staff Management.” Journal of Oncology Practice 4, no. 6 (2008): 305–309. Accessed 
November 11, 2019. http://ascopubs.org/doi/10.1200/JOP.0866501. 
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most enrollments in 6 months.22 Another retention strategy is creating a culture of team 
support.  
5.2.4 Workload Management 
 A CRC may have multiple research protocols that vary in complexity, several 
participants enrolled, preparation for study visits, and/or the amount of data abstraction to 
be completed. Before a PI decides to accept another research project it is in the best 
interest of the CRC to assess the current workload and then determine how much time 
and effort is needed for the new project. A validated tool used to measure the complexity 
of a protocol, provided in this guide, was obtained from an Association of Clinical 
Research Professionals (ACRP) magazine article. The tool is useful in assessing the 
CRC’s workload capacity and to adequately staff a research program to decrease burnout.  
 Another option for the PI is creative staffing which is finding ways to offload 
some of the CRC’s work burden by utilizing other staff members in the department or 
new hires. The Guide provides ideas and tips in this section. 
5.2.5 Evaluation and Feedback 
 The guide provides a Performance Review tool, created by this author, with five 
SMART objectives designed specifically for a CRC. The objectives are specific, 
measurable, achievable, relevant, and time-oriented. Objective 1: Protocol 
Implementation evaluates the percentage of time study visits are scheduled within the 
appropriate time frame, completion of required tests and procedures, timely completion 
of data entry, query response time, and accuracy of the source documentation in the 
                                               
22 Ibid     
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electronic medical record (EMR). Objective 2: Planning and Organizing Study Visits 
evaluates how well the CRC communicates with the study participant as well as other key 
providers to reduce missed visits. Objective 3: Protocol Consent and Eligibility evaluates 
compliance with Federal Policy and the avoidance of protocol violations. Objective 4: 
Safety evaluates the CRC’s ability to report Adverse Events, Serious Adverse Events, and 
Endpoints according to the protocol to avoid violations and deviations. Objective 5: 
Professional Development assesses both the timeliness of required training as well as the 
self-initiatives, based on a tier point system. There is guidance on how often feedback 
should be provided as well as provisions for performance rewards.  
5.2.6. Handing Over of the CRC Project  
 
 Clinical Research Coordinator (CRC) turnover is not always caused by burnout. A 
CRC may leave due to career and/or life changes such as retirement. This guide provides 
a handover checklist for the PI to follow to smoothly transition the project to a new 
coordinator. This checklist includes the key element of notifying the research participants 
as soon as possible. This is done as a courtesy, especially for the participant who has 
bonded with that CRC. The CRC should introduce them to the new CRC if possible to 
help alleviate their potential anxiety and hopefully retain their participation in the study.23 
The checklist also includes any information about the participants that may be helpful as 
well as outstanding items that need to be followed upon.    
  
                                               
 23 Krys. “Why Effective Handover in Clinical Trials Is Important.” Affinity Clinical Research Services. 






Chapter 6: Project Results and Discussion 
6.1. Project Result 
 The result of this project is the creation of a guide to assist Principal Investigators 
in the management and support of Clinical Research Coordinators. It is a one-stop 
resource with a vast amount of information that is succinct and easy to follow. It gives 
the Investigator insight into the extensive training and educational needs of a CRC. It 
shows a new PI the vast amount of details involved in conducting clinical trials.  
 The literature reviewed has acknowledged the value a highly qualified CRC 
brings to the successful implementation and conduct of a clinical trial. The guide 
provides helpful tips and tools on how to manage the CRC’s workload, thus preventing 
burnout. It shows how to effectively communicate expectations, as well as how to 
promote job satisfaction.    
 Based on the author’s research and experience, the CRC Training Tool and the 
Protocol Feasibility Form were created and are provided in the appendix guide.  The tools 
may apply to most protocols or they can be customized.  The guide has been reviewed 
and approved by the Director of Clinical Research for the Food Allergy Program, whose 









Chapter 7: Recommendations and Discussion 
7.1. Recommendation 1: Ensure the guide is accessible 
 The CRC Management Guide should be readily accessible to Investigators and 
senior CRCs both electronically as well as by hard copy. The electronic copy may be 
filed on the IAR BCM website. The Guide will be especially useful to new PIs as it will 
provide insight into the conduct of a clinical research trial.  
 The Guide should also be shared with others within the institution such as the 
BCM Sponsored Program Office (SPO) as they have a wide outreach to PIs, with the 
disclaimer that it was developed based on the needs of the IAR department.  It may also 
be shared with fellow PIs within sponsored networks. 
7.2 Recommendation 2: Updates and revisions 
 A biennial review is recommended to ensure information is up to date, the 
hyperlinks continue to work, and contact information is correct. Also, make sure 
recipients outside of the IAR department understand they are free to revise, customize, 
and/or update their copy of the guide to apply it to their specific needs. 
7.3 Discussion 
 Conducting clinical research trials has become more complex and heavy with 
regulatory requirements. This can be discouraging to Investigators who are often 
physicians with minimal protected research time. Besides, most PI’s are unaware of the 
benefit of having a highly qualified CRC. Using this guide as a resource will provide the 
help many PIs need to successfully conduct clinical trials.   
19 
 
Chapter 8: Conclusion 
  The conduct and implementation of clinical research require meticulous attention 
to detail, especially in the area of regulatory compliance. Noncompliance may result in 
the loss of grant funds, create a negative impact on the reputation of the PI as well as the 
institution, and hinder the procurement of future funds. Although the PI is ultimately 
responsible for all activities conducted at his/her site, a highly qualified CRC can 
significantly make a difference in the success of a research program. 
 In the experience of the author, there are gaps in knowledge of, not only what 
constitutes a highly qualified CRC, but how to keep them motivated to do the tedious 
work required of them. Also, it takes a significant amount of time for the PI to gather a 
minimal amount of references, tools, and information from multiple sources. Therefore, 
the experience of developing this guide has been extremely gratifying. The thought of 
this resource contributing to excellent clinical research that paves the way for new 













Davis, Arlene M., Sara Chandros Hull, Christine Grady, Benjamin S. Wilfond, and Gail E. 
Henderson. “The Invisible Hand in Clinical Research: The Study Coordinator’s Critical 
Role in Human Subjects Protection.” The Journal of Law, Medicine & Ethics 30, no. 3 
(2002): 411–419. Accessed November 11, 2019. 
http://journals.sagepub.com/doi/10.1111/j.1748-720X.2002.tb00410.x. 
 
“Effective Staff Management.” Journal of Oncology Practice 4, no. 6 (2008): 305–309. 
Accessed November 11, 2019. http://ascopubs.org/doi/10.1200/JOP.0866501. 
 
“Good Clinical Practice Network.” ICH GCP / Good Clinical Practice. https://ichgcp.net/. 
 
Johanson, Heather. “Development of a Research Handbook: A Guide For New 
Researchers.” Research Administration, Johns Hopkins University, 2018. 
http://jhir.library.jhu.edu/handle/1774.2/61842. 
 
Kamath, Preeti. “A Manual For Applying To The NIH Collaborative UG3/UH3 Clinical 
Trial Announcement: PAR-18-407.” Research Administration, Johns Hopkins Universtiy, 
2019. http://jhir.library.jhu.edu/handle/1774.2/61776. 
 
Krys. “Why Effective Handover in Clinical Trials Is Important.” Affinity Clinical Research 
Services. Last modified June 23, 2016. https://affinityresearch.com.au/why-effective-
handover-in-clinical-trials-is-important/. 
 
Medina, Angelica. “Creating, Training, and Implementing the Safety Reporting Process for 
a Research Organization’s New Clinical Trials Program.” Research Administration, 
Johns Hopkins University, 2018. http://jhir.library.jhu.edu/handle/1774.2/59864. 
 
“NIH, National Institute of Allergy & Infectious Disease (NIAID).” Rules and Policies for 
Clinical Research. Last modified July 18, 
2018.https://www.niaid.nih.gov/research/clinical-research 
 
“Orientation Manual for Clinical Research Coordinators. Maine Medical Center Research 




“Pediatric HIV/AIDS Cohort Study (PHACS),” National Institute of Child Health and 
Human Development, accessed December 2019, 
https://www.nichd.nih.gov/research/supported/phacs 
 
Speicher, Lisa A., Gregg Fromell, Sue Avery, Donna Brassil, Lori Carlson, Erika Stevens, 
and Michele Toms. “The Critical Need for Academic Health Centers to Assess the 
Training, Support, and Career Development Requirements of Clinical Research 
21 
 
Coordinators: Recommendations from the Clinical and Translational Science Award 
Research Coordinator Taskforce*.” Clinical and Translational Science 5, no. 6 (2012): 




Zink, Holly. “Department-Centered Research Administration: Building a General Research 
Administration Support Program (GRASP).” Research Management Review, The Journal 


































Appendix 1: Guide for Clinical Research Coordinator Management 
  
 
A Guide for Clinical Research Coordinator Management and Support 
2020 Edition 
Chivon McMullen-Jackson 
Texas Children’s Hospital  
Department of Immunology Allergy and Retrovirology 
















 The guide intends to provide a single point of reference for Principal Investigators 
(PIs) who manage and support Clinical Research Coordinators (CRCs), at Baylor College 
of Medicine, Texas Children’s Hospital, in the Departments of Immunology Allergy & 
Retrovirology (IAR) and Rheumatology. This guide will be a resource for PIs and/or 
Senior Coordinators who mentor and train the CRCs.  
 To have a successful clinical research program, it is key for departmental 
leadership to understand the needs of the CRC.1 While the PI has overall responsibility 
for the conduct of a research clinical trial, it is the CRC who provides the fundamental 
structure necessary to organize, maintain, and administer the clinical trial program.2 This 
guide also details the general knowledge and direction necessary for curating an 






                                               
1 Wendy Smith, et al. “A Survey of Clinical Research Coordinators in the Cooperative Group Setting of the 
American College of Radiology Imaging Network (ACRIN).” Academic Radiology 17, no. 11 (July 22, 
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Chapter 1: Talent Selection of a Clinical Research Coordinator  
 
The success of a clinical research program relies heavily upon a Clinical Research 
Coordinator’s (CRC’s) ability to effectively manage day-to-day study-related activities. 
The challenge is finding the ideal CRC, especially given the complexity of most clinical 
trials. A well-designed talent selection process increases the chances of selecting the best 
candidate. This process involves developing an applicable job description, identifying 
and screening the pool of applicants, and implementing a well-planned and structured 
interview.3    
 1.1. Job Description Qualifications  
  Developing a job description requires collaboration with Human 
 Resources. The job description should have details about the research the CRC 
 will be working on. This will enable an astute applicant to prepare for the 
 interview by proactively looking up information about the research project. The 
 job description should list qualifications that describe some of the essential 
 attributes of a CRC. Such qualifications should include experience, education, and 
 training. 
                                               
3 Cyenthia Willis, et. al. “The Anatomy of a Great Clinical Research Coordinator.” The Association of 






  1.1.1 Experience 
A CRC who has at least one to two years of experience in consenting 
and enrolling human research participants is preferable. Prior clinical 
research experience of at least two years is required when the clinical trial 
involves an Investigational New Drug (IND). Studies with INDs require 
extensive knowledge of when and how to recognize and report Serious 
Adverse Events (SAEs) and Adverse Events (AEs) to ensure the safety of 
the research participant. 
  1.1.2 Education 
At a minimum, a bachelor’s degree in the life sciences and/or 
nursing fields will be the level of education needed to conduct the type 
of clinical trials performed in the Departments of Immunology Allergy 
& Retrovirology (IAR) and Rheumatology. An undergraduate degree in 
any other field may require at least two years of clinical research 
experience.  
A certification in research administration is preferred, such as the 
Certified Clinical Research Professional (CCRP) certification obtained 
from the Society of Clinical Research Associate (SoCRA).4 Another 
research organization that offers certifications is the Association of 
Clinical Research Professionals (ACRP).5 
                                               
4 “Society of Clinical Research Associates (SoCRA).” SoCRA, Accessed February 2020, https://www.socra.org/. 





  1.1.3 Prior Training Specifications 
A very small percentage of entry to mid-level applicants have formal 
clinical research training. 6 Therefore, it is important to look for other 
attributes or competencies during the interview process. The 
recommended competencies are discussed in detail in section 1.3.   
An applicant should be able to articulate prior training in ethics and 
regulatory compliance, specifically in Federal Policy for the Protection of 
Human Subjects, 45 CFR part 46.7 This training should include general 
knowledge of and documentation requirements of informed consent, 
Investigative Review Board (IRB) reporting of protocol deviations, and 
reporting amendments or changes to the protocol.   
 1.2 The Interview Process 
 Make the interview matter by taking time to prepare for activities that 
 must occur before, during, and after the interview. Before the interview, a select 
 panel of interviewers should take the time to carefully review each resume. 
 During the interview,  a variety of behavior-based questions should be asked.8 
 Behavioral-based questions can assess how the candidate handled various work 
                                               
6 Wendy Smith, et al.  “A Survey of Clinical Research Coordinators in the Cooperative Group Setting of the 
American College of Radiology Imaging Network (ACRIN).” Academic Radiology 17, no. 11 (July 22, 
2010): 1449–54. https://doi.org/10.1016/j.acra.2010.06.002. 
7 “Department of Health & Human Services (DHHS).” Office for Human Research Protections. Last modified March 
18, 2016. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/common-rule/index.html  
8 Cyenthia Willis, et.al.“The Anatomy of a Great Clinical Research Coordinator.” The Association of Clinical 






 situations in the past. Examples of behavior-based questions that may assess 
 problem solving, adaptability, and work standards include: 
• When you worked on multiple projects how you did prioritize? 
• Tell me about a time you were under a lot of pressure? How did you get 
through it? 
• Describe a time when you found a problem and took the initiative to 
correct it rather than wait for someone else. 
• Describe a time when you had to work with a difficult research 
participant/customer. How did you handle it?  
 After the interview, subjective feedback from each interviewer should be 
 documented on the Interview Feedback Form (IFF) discussed in section 1.3. 
  1.2.1 Planning the Interview 
  It is optimal to have a panel of at least three experienced CRCs 
within the department who are familiar with the research project the 
candidate is applying for. The interview panel should review resumes and 
highlight the qualifications and/or attributes that meet the requirements for 
the job, thereby increasing the likelihood of selecting the top candidates.9 
   Determine which behavior-based questions will be asked during  
  the interview and who will ask them. While one interviewer is asking the  
  questions another should be writing down the answers.  The interviewer  






  asking the questions should encourage the candidate to respond using the  
  STAR method: (S) Situation- describe the situation in which the event  
  took place; (T) Task- describe the given project or responsibility and the  
  issue that had to be resolved; (A) Action- explain the action taken to  
  resolve the problem; (R) Results- provide the outcome of the action that  
  was taken.10  
 1.3 Competencies Listed on the Interview Feedback Form (IFF) 
 The Texas Children’s Hospital (TCH), Human Resources Department, 
 developed staff Success Profile Competencies that provide the definitions used on 
 the Interview Feedback Form (Appendix I). Although competencies are used by 
 TCH for the purpose of employee performance evaluations, they are useful in 
 providing objective guidance in selecting a CRC.  
 The panelists should review the IFF and familiarize themselves with the 
 list of competencies. There is a brief description of the competencies, a rating 
 scale of 1 to 5, and a section for comments. The CRC candidate will not be 
 selected solely based on the ratings on the feedback form. The feedback form will 
 provide the basis for a discussion among the panelists and the PI prior to making 
 the final selection. 
                                               







The six competencies selected for the IFF are based on some of 
the qualities and skills that are necessary for a CRC to successfully conduct 
research. The competencies are 1) Interpersonal Sensitivity, 2) Decision 
Making/Problem Solving, 3) Planning and organizing, 4) 
Technical/Professional Knowledge and Skills, 5) Work Standards, and 6) 
Adaptability.11  
  1.3.1. Interpersonal Sensitivity 
   The CRC may encounter research participants from diverse  
  backgrounds and/or socioeconomic status. It is to the advantage of the  
  CRC to be able to build a rapport with potential study participants. During 
  the screening/consenting process the CRC should be able to help the  
  participant feel comfortable, assess whether or not the time is appropriate,  
  and any needs the participants may have. If there are literacy concerns, the 
  CRC must be able to approach them in a non-judgmental manner. The  
  development of this initial relationship may lead to better adherence and  
  retention throughout the study’s lifecycle.12  
  1.3.2. Decision Making/Problem Solving 
A CRC must anticipate problems and use good judgement when 
making decisions. For example, the CRC may need to promptly report any 
                                               
11 “Texas Children’s Hospital.” Institution. Department of Human Resources, Performance Management, April 2015. 
12 Cyenthia Willis, et. al. “The Anatomy of a Great Clinical Research Coordinator.” The Association of 






adverse events that are anticipated and/or unanticipated, usually within 24 
to 48 hours for an SAE, based on protocol guidelines or the CRC may 
need to create solutions to problems that may potentially lead to loss of 
funding (i.e. not meeting enrollment targets, electronic data entry that is 
consistently late, tests and procedures that are consistently missed, etc.).13  
  1.3.3. Planning and Organizing 
 A key attribute of a successful study is the organizational 
capabilities of its CRC.14 Disorganized and/or missing study records and 
regulatory documents may lead to protocol deviations, data that can’t be 
analyzed, damage to the PI’s reputation, and loss of funding. The CRC 
candidate should be able to give examples of how she/he maintained 
organization at a previous job (i.e. use of excel spreadsheets that are 
updated weekly, checklists, etc.) 
  1.3.4. Technical/Professional Knowledge and Skills 
   Leveraging technology allows the CRC to keep up with the current 
  trends  in clinical research. There are tremendous opportunities in social  
  media, cloud computing, electronic consenting, direct data entry (DDE),  
  telehealth study visits, etc., to drive efficiencies and reduce costs.15 The  
  CRC may also need to develop materials and tools, such as quick   
                                               
13 Ibid 
14 Ibid 
15 Priya Temkar. “Clinical Operations Generation next...The Age of Technology and Outsourcing” 6, no. 4 (December 





  reference guides, to enhance study performance. Therefore, basic skills in  
  Word, Excel, and PowerPoint are essential. 
  1.3.5. Work Standards 
 The CRC must have a strong set of values based on the ideals of 
discipline and hard work, staying motivated, and finishing tasks on time. 
For example, as the CRC abstracts and inputs data from many sources, 
she/he must ensure the data is timely, accurate, reliable, and valid.16 Also, 
the CRC must ensure Good Clinical Practice is adhered to even when 
faced with deadlines and the pressure to meet certain targets. A high-
principled CRC will self-impose work standards of excellence rather than 
having standards imposed and assumes a leadership role.17  
  1.3.6. Adaptability 
   The CRC must remain composed when faced with challenging  
  circumstances. There may be an instance where a study participant  
  becomes angry and/ or she/he is challenged with the addition of a complex 
  protocol when the current workload is at a maximum. The CRC must be  
  able to quickly come up with a solution and/or be able to communicate to  
  the PI when there is a need for additional assistance.  
  
  
                                               






Chapter 2: Orientation of CRC Once Hired 
 
 The process of training and onboarding a new CRC may take up to 6 months. It is 
in the best interest of the clinical research program and the CRC to ensure basic training 
is conducted before the CRC performs any study related activity. The basic training 
includes research ethics and regulatory compliance; protocol specific activities related to 
the informed consent process, eligibility, and participant safety; documentation; and data 
entry. The later phase of training includes study closeout procedures, site monitoring 
visits, assistance with grants and contracts, and determination of protocol feasibility. 
 2.1. Training: Federal, State and Institutional Regulations 
 The first two weeks must be devoted to the ethics of conducting Human 
 Subjects Research. The PI and/or Senior Coordinator, designated as the CRC 
 preceptor, must set the tone that all research activity must be conducted with the 
 highest ethical, legal, and scientific standards in accordance with the Federal, 
 State, and Institutional regulatory requirements.18 The CRC must be familiar with 
 the purpose of each Federal Regulation and its associated agency, and how to 
 access the BCM training. 
 2.1.1 Federal Regulations: Department of Health and Human Services  
  (HHS) 
                                               
18 “Orientation Manual for Clinical Research Coordinators. Maine Medical Center Research Institute.” 







The Office of Human Research Protections (OHRP) provides 
guidance and maintains regulatory oversight in the protection of the rights, 
welfare and wellbeing of participants involved in research conducted or 
supported by the U.S. Department of HHS.19  
  2.1.2 Code of Federal Regulations (CFR) 
  The HHS Code of Federal Regulations, 45 CFR part 46, includes  
  four subparts: Part A, the Federal Policy, also known as the “Common  
  Rule”; Part B, additional protections for pregnant women, human fetuses,  
  and neonates; Part C, additional protections for prisoners; and Part D  
  additional protections for children.20 




  2.1.3 The Food and Drug Administration (FDA) 
  The FDA is an HHS agency that regulates clinical investigations of 
  products such as prescription and non-prescription drugs; biologics  
  including vaccines for humans, blood and blood products, cellular and  
  gene therapy products, tissue and tissue products, allergenics; and medical 
  devices including heart pacemakers, surgical implants, and prosthetics.21 
                                               
 19 “Department of Health & Human Services (DHHS).” Office for Human Research Protections. Last 
modified March 18, 2016. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/common-
rule/index.html. 
20 Ibid 





 U.S. Food and Drug Administration website: https://www.fda.gov/ 
  2.1.4 International Council for Harmonisation (ICH) 
  The ICH of Technical Requirements for Pharmaceuticals for  
  Human Use responds to the global reach of drug development.22 The  
  ICH’s mission is to overcome international Good Clinical Practice (GCP)  
  inconsistencies throughout countries. Some of their guidelines are more  
  stringent than the FDA. 
   2.1.4.1 Good Clinical Practice (GCP) 
   ICH-GCP is a harmonized standard that ensures the clinical 
   trial data is credible, protects the rights, safety, and well-being of  
   human  research participants, minimizes human exposure to  
   investigational products, improves quality of data, speeds up  
   marketing of new drugs, and decreases the cost to sponsors and the 
   public.23 
International Council for Harmonisation website: 
https://www.ich.org/ 
  2.1.5 BCM Institutional Regulations  
Personnel at Baylor College of Medicine (BCM) involved in human 
research are expected to understand and apply their obligation to protect 
                                               
 22 “International Council for Harmonisation.” Last modified April 20, 2020. https://www.ich.org/. 
 23 Vijayananthan, A, and O Nawawi. “The Importance of Good Clinical Practice Guidelines and Its Role in 






the rights and welfare of research participants, by following the BCM 
Human Research Protection Manual. 24  
The BCM Human Research Protection Manual can be found on the 
BCM intranet website: 
https://intranet.bcm.edu/apps/research/oor/a_c/document/irb_manual.pdf 
  Baylor utilizes the Collaborative Institutional Training Initiative  
  (CITI)  online training. Documentation of current course certificates from  
  CITI is required before institutional approval for conducting research. The 
  CRC should complete courses under a Baylor College of Medicine CITI  
  institutional profile where a minimum score of 80% is required for each  
  course. Courses must be taken at the frequency indicated in Table 1.   
  As shown in Table 1, BCM requires the completion of the CITI  
  Good Clinical Practice (GCP) course for research that involves FDA- 
  regulated clinical trials to be completed every 3 years. Health Information  
  Privacy and Security (HIPs, IPS) and Human Subject Research (HSR)  
  must also be completed every 3 years and the Research Conflict of Interest 
  (COI) must be completed every 4 years. To ship any biological specimens  
  a certificate must be obtained from the BCM online course  every 2 years.  
 
 
                                               








Table 1. BCM Required Regulatory Training 
CITI Program Online Training: https://about.citiprogram.org/en/homepage/ 
CITI Course Name Frequency 
Good Clinical Practice (GCP) 
Required for individuals conducting FDA-regulated 
clinical trials 
Every 3 years 
Researcher Conflict of Interest (COI) Every 4 years 
Health Information Privacy and Security (HIPS) Every 3 years 
Human Subjects Research (HSR) - Biomedical 
Research Basic & Refresher 
Refresher module only required every three years 
Every 3 years 
Shipping Biological Specimens 
Required for CRCs who handle or ship biological 
specimens including human blood and tissue.  
 
The BCM Office of Environmental Safety (OES) IATA 
training certificate is acceptable 
Every 2 years 
 
 Baylor also has a series of seminars, workshops, and other online   
  training, all of which the CRC will need to attend including:   
• Informed Consent Workshop: A 2-hour interactive workshop that 
provides an overview of Informed Consent and Assent processes in 
clinical research, provides familiarity with applicable regulations and 
requirements, discusses quality improvement and consent 
monitoring, and provides relevant contacts and resources.  
 To register for the workshop please call 713-798-4223 or e-mail 





• Research Investigator Workshop: This hands-on, practical 
workshop addresses a wide array of research issues and regulatory 
requirements, including fundamental topics such as a brief history of 
human subject research, applicable regulations, BCM IRB 
Procedures, Good Clinical Practices, recordkeeping, required IRB 
submissions, and how to navigate the Biomedical Research and 
Assurance Information Network (BRAIN), the BCM electronic IRB 
system. Includes tips for a smoother submission and approval 
process. 
Please contact Research Compliance Services (RCS) at 
researchcomplianceservices@bcm.edu  for more information 
• International Air Transportation Association (IATA) Biological 
Shipping Online Training: This covers the transport of Class 6.2 
infectious substances (blood, other bodily specimens, etc.) and Class 
9 miscellaneous substances (dry ice and genetically modified 
organisms), shipper’s responsibilities, and penalties for 
noncompliance. 
For questions concerning accessing the Environmental Safety online 
training, please contact Rebecca Luke at 713-798-6651 or 
rms1@bcm.edu  
• Lab Blood borne Pathogen Training: This training focuses on how 
pathogens like HIV, HBV, and HCV are transmitted and how to 
minimize the risk of exposure through universal precautions and the 
use of appropriate personal protective equipment (PPE).For 
questions concerning accessing the Environmental Safety online 
training, please contact Rebecca Luke at 713-798-6651 or 
rms1@bcm.edu  





 The PI or designated preceptor will use the Protocol Specific Training  
 Tool (see Appendix II) as a guide. The training tool includes a review of protocol  
 materials, training provided by the sponsor, essential protocol elements, the  
 informed consent process, and regulatory documentation.  
 The CRC may independently review the protocol materials including,  
 the latest version of the protocol, the manual of operating procedure (MOP), and  
 the laboratory processing manual. The CRC may attend an online webinar or an  
 in-person workshop provided by the sponsor when applicable.  The next items  
 listed on the training tool require a one-on-one conversation with the CRC  to 
 assess the level of understanding of the protocol. 
  2.2.1. Essential Protocol Elements 
  The CRC’s understanding of the essential elements of the protocol  
  reduces the risk of harm to the research participant. This includes the  
  inclusion/exclusion criteria, SAEs, prohibited medications, study   
  endpoints, and schedule of events. 
   2.2.1.1 Inclusion/Exclusion Criteria 
   It is of critical importance that the CRC understands the  
   inclusion and exclusion criteria to determine who is eligible for the 
   study and who is not. Enrolling someone who does not meet the  
   eligibility criteria may lead to a major violation, or much worse,  
   cause harm to the participant, such as giving someone a study  





   2.2.1.2 Serious Adverse Event (SAE)/Adverse Event (AE) 
   When conducting clinical trials that involve treatment, the  
   CRC must be aware of what the study considers an Adverse Event  
   (AE), a Serious Adverse Event (SAE), when and how to notify the  
   sponsor, and the correct form of documentation. The FDA, ICH,  
   and GCP set forth safety monitoring and reporting responsibilities  
   of sponsors and investigators.25 
   According to the FDA definition - an adverse event or  
   suspected adverse reaction is considered “serious”, if, in the view  
   of the investigator, it results in any of the following outcomes: 
• Death 
• A life-threatening adverse event 
• Inpatient hospitalization or prolongation of existing 
hospitalization 
• A persistent or significant incapacity or substantial 
disruption of the ability to conduct normal life functions or a 
congenital anomaly/birth defect 
• Important medical events that may not result in death, be 
life-threatening, or require hospitalizations may be 
                                               
 25 “NIH, National Institute of Allergy & Infectious Disease (NIAID).” Rules and Policies for Clinical 





considered serious when, based upon appropriate medical 
judgement, they may jeopardize the patient or subject and 
may require medical or surgical intervention to prevent one 
of the outcomes listed in this definition.26 
Any AE that meets a protocol-defined serious criterion must be 
submitted to the sponsor immediately (no more than 24 hours of site 
awareness).27 
   2.2.1.3 Prohibited Medications While on Study 
   When a treatment protocol has a list of prohibited   
   medications that may cause drug-to-drug interactions with the  
   study agent, the CRC must assess the participant’s concomitant  
   medications at screening, entry, and each study visit thereafter. The 
   PI and sponsor must be notified immediately, if and when the CRC 
   becomes aware of the participant taking any of these medications,  
   to determine next steps.   
  2.2.1.4 Study End Points     
   The CRC must be aware of the endpoint or outcomes  
   determined by the study to indicate whether the treatment is  
   beneficial or showing signs of toxicity. This may be determined by 
   clinical assessment or  laboratory testing. If a laboratory test is  







   abnormal it may require repeating the test. If the test remains  
   abnormal this may require taking the participant off study. That is  
   why all safety labs must be checked within 24 hours of the blood  
   draw and reviewed by the PI/Sub-I. 
   2.2.1.5 Schedule of Events 
   The schedule of events is a list of tests, procedures, and  
   questionnaires that must be completed at different time points  
   throughout the life of the study. The schedule provides specific  
   time points or research visits in days, weeks, months and years.  
   The CRC will need to create a checklist for each visit to ensure all  
   study procedures and tests are performed. Every missed test and  
   procedure will be considered a protocol deviation. When there is a  
   protocol deviation a detailed explanation of the cause must be  
   recorded in the participant’s study record.  
  2.2.2 Informed Consent/Assent Process 
Obtaining Informed Consent of human research participants before 
involving them in research is one of the protections provided under the 
HHS regulations at 45 CFR part 46. It is founded on the principle of respect 
for persons, as described in the Belmont Report.28 The Informed Consent 
                                               
28 “Department of Health & Human Services (DHHS).” Office for Human Research Protections. Last 






Process requires that participants, to the degree that they are capable, be 
allowed to know what is going to happen to them (or not) during the entire 
course of the study.29   
  The CRC must be familiar with the different requirements and/or  
  restrictions for the vulnerable populations and those requiring special  
  protections (infants, children, adolescents, and pregnant women) who are  
  recruited in the IAR and Rheumatology departments. In the case of minors 
  (children below the age of 18 years) a Legally Authorized Representative  
  (LAR) must give consent. The BCM IRB will determine the age a child  
  less than 18 must provide assent, by following the rules in 45 CFR part  
  46.408.30 During the assent process, the CRC explains the study in   
  language the minor may understand. The child must provide   
  an affirmative answer in order to participate in the study.  
  The IRB may also determine if one or both parental signatures are  
  required based on the risk category: 1) not involving greater than minimal  
  risk, 2) greater than minimal risk with benefit, 3) greater than minimal risk 
  with no benefit, 4) does not meet conditions of 1, 2, or 3 (45 CFR 46.404  
  to 46.407).  
                                               
29 Ibid 






The BCM IRB requires the signature of both parents for risk 
categories 3 and 4 unless one parent is deceased, unknown, incompetent, 
or not reasonably available, or when only one parent has legal custody or 
responsibility for the care of the child.31 Once the minor reaches the age of 
18 years and is still enrolled in the study, he/she must re-consent as an 
adult. 
  Pregnant mothers may sign consent for themselves, unborn child  
  and neonate if there is direct benefit to her and no greater than minimal  
  risk to the fetus.32 Consent of the pregnant mother and the father is  
  required if research offers direct benefit only to the fetus. However,  
  father’s consent is not required if he is unavailable, incompetent,   
  temporarily incapacitated, or the pregnancy resulted from rape or incest.33 
  An emancipated pregnant minor may be able to sign consent for  
  herself  and her baby as determined by the state law and the IRB. In the  
  state of Texas a minor petitioning a court for emancipation must be a  
  Texas resident, 17 years old (or 16 and living apart from one’s parents),  
  and able to support and manage one’s own affairs.34 
                                               










  Once the PI/preceptor has determined the CRC’s understanding of  
  the basic Federal and institutional guidelines of consenting, the CRC can  
  move to the next phase of training which includes the observation of a  
  study participant being consented on a study. Then the CRC must role- 
  play consenting with the PI/preceptor. 




  2.2.3 Regulatory Assessment 
The CRC will meet with the Regulatory Coordinator (RC) and 
submit all training documentation. The RC will provide the CRC access to 
the protocol (s) in the Biomedical Research and Assurance Information 
Network (BRAIN) where the CRC will be instructed to always print the 
consent form in real-time before use. Printing in real-time rather than 
using a stored copy ensures the use of the most up-to-date consent form. 
The RC will also have the CRC sign the protocol-specific 
Delegation of Duties Log (DodL). The DodL specifies the roles and 
responsibilities of all personnel who participate in the conduct of a study 
and is mandated by all sponsored trials. The sponsor will check to see if 
research staff are adequately trained in their assigned roles. 
A standard NIH approved Delegation of Duties Log (DoDL) template 







 2.3 Documentation and Essential Record Keeping Requirements 
 To ensure the quality and integrity of research data, source documentation 
 must be based on the ALCOA method: Attributable- is it obvious who wrote it? 
 Legible-can it be read? Contemporaneous- is the information current and in the 
 correct time frame? Original- is it a copy, has it been altered? Accurate- are 
 conflicting data recorded in other places?35 
  2.3.1 Informed Consent/Assent Form Documentation 
  The consent form should be signed and dated before any research- 
  related  procedures are conducted with a participant in a clinical trial. The  
  process of obtaining consent should be documented in the research record  
  and should include: the time, especially important when consent occurs on 
  the same day as enrollment/ randomization; a description of the consent  
  process to show that it was not coerced; information about the study  
  including all available options and that it was spoken in a language  
  understood by the participant; the participant was given adequate time to  
  consider all options; questions were answered, and comprehension was  
  assessed.36  
  When obtaining consent for a minor the documentation must show  
  the consent of the person of legal authority and that the study was   
                                               
35 “NIH, National Institute of Allergy & Infectious Disease (NIAID).” Rules and Policies for Clinical 






  explained in an age appropriate manner for a child who is in the age range  
  mandated by the IRB to obtain assent. This may be in the form of a  
  separate assent form and/or documented in the medical record as   
  determined by the IRB and the sponsor. 
  The CRC must also document that he/she gave the participant a  
  copy of the consent and place another copy in the medical record. The  
  original consent form must be stored in a research file with limited access  
  to the research staff only. 
  2.3.2 Computerized Records/Electronic Medical Records 
   Printouts retrieved from the electronic medical record (EMR) are  
  considered copies and are not the original record.37 The electronic data in  
  the computer system is considered the original source. Therefore, the CRC 
  must ensure that the electronic signature along with the date and time of  
  execution is visible at the bottom of the printed document.  
   A letter from the institution or the PI must certify that the   
  electronic signature in the computer system is intended to be the legally  
  binding equivalent of the traditional handwritten signature.38 The   
  certification may be in the form of an institutional policy. 
 2.4. Data Entry and Record Retention 
                                               
 37 “NIH, National Institute of Allergy & Infectious Disease (NIAID).” Division of AIDS (DAIDS) Clinical 







  The CRC must maintain and secure complete Case Report Forms (CRFs), 
 data collection forms, or direct data entry, into the protocol-specific database, 
 within 2 to 3 weeks of the participants’ study visit. All data must be verifiable by 
 the source documentation.39 
  The CRC must meet with the Data Coordinator weekly to ensure queries 
 and delinquent data are addressed promptly. Before transmitting data with 
 protected health information (PHI) to sponsor, IRB, and regulatory agencies all 
 documentation must be de-identified. 
Clinical research records are required by the HHS regulations 45 CFR 
46.111(b) and must be retained for at least 3 years after completion of the 
research, including completion of data analysis.40 
  For research also subject to FDA IND regulations 21 CFR 312.62(c), the 
 PI is required to retain research records, case histories, safety reports, final 
 reports, and final disclosure reports and records of drug disposition. Case histories 
 include case report forms and supporting data (e.g. signed and dated consent 
 forms, medical records, doctor’s progress notes, nurse’s notes, and individual 
 hospital records).41 
                                               
 39 “Orientation Manual for Clinical Research Coordinators. Maine Medical Center Research Institute.” 
Main Medical Center, Maine Health. Last modified 2009. 
https://www.mmcri.org/deptPages/em/downloads/CRC_Orientation_Manual/CRC_Orientation_Manual.pdf 
 40 “NIH, National Institute of Allergy & Infectious Disease (NIAID).” Division of AIDS (DAIDS) Clinical 







 2.5 Study Close-Out 
 The CRC will coordinate close-out procedures according to the protocol. 
 This may include contacting research participants with final information and/or 
 instructions, transitioning them to a routine care provider, and/or making sure 
 there are no gaps in access to medication.  
 The final disposition of remaining study supplies may need to be arranged, 
 as well as notification of all team members including participating departments. 
 The CRC may also assist the PI and the Grants and Contracts team with data 
 needed for the Research Performance Progress Report (RPPR) due within 30 days 
 following the grant end date.   
The NIH RPPR Instruction Guide website:  
 https://grants.nih.gov/grants/rppr/rppr_instruction_guide.pdf 
 2.6 Site Monitoring Visits 
 Research sponsors generally contract with agencies to hire clinical site 
 monitors who perform on-site and/or electronic review of source documentation, 
 participant records, regulatory files, facilities, laboratories, and pharmacies.  
 Although the PI is ultimately responsible for the overall preparation, inspection 
 activities, and correction of deficiencies identified during the monitoring visit, the 
 CRC is usually the main point of contact for the site monitor. 42 
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 The CRC must prepare for activities before, during, and after the site 
 monitoring visit. Once the monitor has secured the visit date, the CRC must 
 reserve adequate space for the monitor, notify all involved study personnel of the 
 visit, and assure those study subject binders and original source documents are 
 available for data verification. The CRC must also assure that all screening logs 
 and signed informed consents are available.  
 During the monitoring visit, the CRC and the RC will greet the monitor, 
 establish meeting times with the PI and other staff as needed, and schedule the 
 debriefing. They will also be available during the entire visit to answer questions 
 and retrieve additional records as needed. During the debriefing, the monitor 
 should notify the site of any findings that he/she identified. The site PI may ask 
 the monitor to provide relevant regulations to justify any of the findings that are 
 questionable. 
 After the visit, the PI and the CRC must prepare answers for any and all 
 findings noted during the visit. The final report must be carefully reviewed and a 
 written response provided promptly, no later than the specified due date. 
 2.7. Grants and Contracts Overview 
 The Clinical Research Coordinator (CRC) works in partnership with the 
 grants and contracts section of the IAR department. The CRC provides the 
 clinical information that is necessary to accurately prepare the budget and build 
 the protocol into the institution’s electronic Clinical Trial Management System 





 The CRC will assist in preparing the budget by determining the amount of 
 effort needed to perform tasks and procedures, the type and amount of supplies 
 needed throughout the study, other departmental collaborations such as 
 diagnostics, participant payments, and any other potential expenses. During the 
 study, the CRC assists with the review and reconciliation of finance charges. 
 2.8 Preparation for Site Selection of a New Protocol and Initiation Visit 
  One of the more advanced responsibilities of the CRC is to help determine 
 the feasibility of the site’s participation in a new protocol. The CRC can provide 
 invaluable insight into the site’s capacity to conduct the study safely and 
 sufficiently. Once the PI decides to participate the CRC starts the preparation for 
 the site initiation visit (SIV). 
  2.8.1 Determination of Feasibility 
A sponsor may contact the PI to determine interest in a protocol and 
to assess whether or not the site is capable of conducting the trial. Initially, 
the site may only receive a synopsis or draft version of the protocol. 
Therefore, it may be difficult to make an informed decision. The CRC 
may use the Clinical Trial Feasibility Form (Appendix III) to fill in the 
gaps and help guide the discussion with the PI and the sponsor.  
The Clinical Trial Feasibility Form lists a series of questions that 
will help to determine if the department has the appropriate population to 





(including staff) and what supplies, if applicable, are needed to conduct 
the study.  
2.8.2 Preparation for Site Initiation Visit 
Once the site has been selected to participate in the new research 
protocol, preparation for a Site Initiation Visit (SIV), sometimes referred 
to as Site Establishment Visit (SEV), must begin. The CRC becomes the 
main point of contact by the sponsor and the following items must occur:43 
• Attend Investigator meetings and/or conference calls. 
• Assist with the preparation and submission of regulatory 
documents. 
• Arrange for receipt and storage of test articles and study supplies. 
• Arrange for adequate supplies of required shipping materials. 
• Train staff according to their respective roles. 
• Document all training. 
• Ensure appropriate staff are available for the SIV. 
  2.8.3 Collaboration with Other Ancillary or Specialty Staff 44 
   The CRC should determine any other ancillary services needed to  
  conduct the new protocol, determine training needs, and meet regularly to  
  mitigate issues in real time. The most common services are as follows: 
• Laboratory 







o Meets with a lab technician to review and plan the required 
activities. 
o Provides Laboratory Procedures Manual or Chart 
o Demonstrates required skills for processing samples 
o Completes IATA hazardous materials shipping training 
 
• Pharmacy 
o Meets with Investigational Pharmacy to review and plan 
required activities 
o Provide Pharmacist with a copy of protocol 
o Develops plan with Pharmacist for: 
 Delivery and storage of investigational drug 
 Dispensing 
 Emergency unblinding procedures 
 Drug accountability 
 
• Data Coordinator 
o Review Case Report Forms (CRFs) 
o Determine CRFs that will be used as source documentation 
o Assist with database training when there is direct data entry 
(DDE) 
 
• Clinical Research Center  
o Meet with manager to give a brief preview of the protocol 
o Provide a copy of the eligibility criteria, study events  
o Provide in-service to staff 
 





o Provide sub-specialist a copy of protocol 
o Review eligibility criteria and recruitment goals 
o Discuss training requirements and study procedures 
o Determine the need for study supplies 














Chapter 3: Retention 
 
 The retention of highly qualified CRCs is especially important because of the time 
it takes to recruit, hire, and train a replacement. There may be a significant loss of 
productivity during this time which contributes to loss in revenue.45 There are several 
mechanisms, other than increase in salary, that may enhance the level of job satisfaction 
for the CRC including, effective communication, opportunities for professional 
development, improving work conditions, performance rewards, and promoting a team 
culture. 
 3.1 Effective Communication 
  Engaging the CRC in the development of the goals and/or plans of the 
 research program shows how much their input is valued. Plan frequent meetings 
 to discuss enrollment targets, challenges, solutions, and the feasibility of taking on 
 new protocols. The meetings should be weekly at the very least. Share the 
 sponsor’s site evaluation reports in a manner that is helpful, with the intent to 
 improve performance. 
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 3.2 Professional Development  
  Investing in the professional development of the CRC is in the best 
 interest of the  clinical research program, as it strengthens their skill set and 
 improves their ability to do their jobs as they develop and grow as a person.46 
  There are several premier professional organizations for clinical research 
 professionals. They are listed here, with a few highlights of what each 
 organization has to offer its members and shown in Table 2 with fees. The Society 
 of Clinical Research Associates (SOCRA) provides high-quality education 
 through workshops, conferences, quarterly journals, live webinars, and weekly 
 newsletters.47 SOCRA is also well known for its certification program. The 
 Association of Clinical Research Professionals (ACRP) is leading the way in 
 regards to innovations in the clinical research workforce by validating standards 
 for professional competence.48 
  The National Council of University Research Administration (NCURA) is 
 ideal for an advanced or more senior CRC. The “Research Management Review” 
 is a scholarly journal of NCURA that deals with a broad range of issues affecting 
 the administration of research and the research environment.49 Also, scholarships 
 are provided to support members who pursue graduate education in research 
                                               
46 Ibid 
47 “Society of Clinical Research Associates (SoCRA).” SoCRA. https://www.socra.org/ 
48 “Association of Clinical Research Professionals (ACRP).” ACRP. https://acrpnet.org/ 





 administration such as the MS in Research Administration course at Johns 
 Hopkins University. 
  Encourage CRCs to pursue other development opportunities such as 
 submitting an abstract to a research conference, attending local and institutional 
 workshops. BCM conducts a monthly compliance workshop, Clinical Research 
 Education (CreED), which offers updates and practical advice on research-related 
 regulations, IRB procedures, and “hot” or commonly misinterpreted topics. The 
 sessions are held in the Cullen building, room 187A, no registration is required. 
 TCH, Research Administration holds a bi-monthly seminar, Clinical Research 
 Education Workshop (CREW), held in Feigin Tower, first floor, Conference 
 Room A. 
 
Table 2. Professional Organization for Clinical Research Professionals 
 
Organization Membership Dues Certification 
Society of Clinical Research 
Professionals (SOCRA) 
www.socra.org  
$75/yrs. Certified Clinical Research Professional (CCRP) 
$350/every 3 yrs. 
Association of Clinical Research 
Professionals (ACRP) 
www.acrpnet.org   
$150/yr. Certified Clinical Research Coordinator (CCRC) 
$435/initial        $250/every 2 yrs. 










 3.3 Improve Work Conditions 
  Meeting the needs of a CRC beyond the office may positively influence 
 work performance and directly benefit the research program.50 This can be done 
 through flexible work schedules that promote work-life balance. The CRC may 
 discuss a preferred work schedule with the PI that should be approved based on 
 the needs of the research program and policies of the institution.  
  Work performance and productivity may also be affected by the office 
 workspace. The PI should occasionally survey the needs, desires, and/or 
 challenges the CRC may face within the work area and take them into 
 consideration during the next budget cycle. 
 3.4. Performance Rewards 
  The Texas Children’s Hospital, Human Resources (HR) department has a 
 merit-based system tied to the performance evaluation (discussed in Chapter 5). 
 Depending on  the market, the merit rate may change from year to year. Therefore, 
 the PI should find other incentives to award performance. Creative ideas may 
 include, a gift card for a massage, lunch, tickets to a movie or play, and/or 
 recognition at a department-wide Town Hall meeting.51 
 3.5. Develop a Team Culture 
                                               
50Gemma Reeves. “Building Culture, Leading People, Skills Shortage.” 7 Ways to Reduce Employee 
Attrition. Last modified 2018. https://www.zippia.com/employer/7-ways-reduce-employee-attrition/. 
51 “Effective Staff Management.” Journal of Oncology Practice 4, no. 6 (2008): 305–309. Accessed 






  A team culture is where everyone works toward a common goal and feels 
 empowered to do so.52 Everyone must feel that they can contribute their ideas 
 toward the goals/plans of the program in order to promote buy-in. This may be 
 accomplished by engaging everyone to contribute to the mission and values of the 
 research program. 
  Texas Children’s Hospital (TCH), Learning Academy, assist with 
 developing a team culture through several courses offered throughout the year. 
 The “i-Team” course teaches individual contributors how to tap into the power, 
 purpose, and skills of being an effective team player. The course provides tools 
 and skill practice around the 5Cs of teamwork: Connecting, Communicating, 
 Collaborating, Conflict Resolution, and Commitment to action. 
  Scheduling activities outside of the work environment may also help to 
 build trust by allowing team members an outlet to get to know one another on a 
 personal level. A few examples of creative team-building exercises include an 
 annual retreat at the home of the PI/CRC, exploring different restaurants on 
 special occasions, attending sports events, or other ideas the team may suggest. 
The TCH, HR, Learning Academy courses can be found on the SharePoint 










Chapter 4: Workload Management 
 
 One of the top motives for a highly qualified CRC to leave a job is burn-out.53 
The role of the CRC evolves throughout the course of the research, as well as the 
complexities of clinical research protocols. Overburdening the CRC has the potential to 
cause delinquencies and gaps in research procedures leading to risks for the participant, 
the PI, as well as the institution.54 A tool that measures the complexity of a protocol will 
help the PI understand the workload of the CRC. 
 4.1. Assessing Protocol Complexity 
  Assessing the complexity of a protocol may help determine the amount of 
 effort needed to adequately staff and conduct a clinical trial. An example of a 
 complexity tool with a scoring matrix is shown in Table 3. Each study element is 
 assigned a point of 1 to 3 based on no, minimal, moderate, or maximum effort. 
  The study elements in the complexity tool include the experience of the 
 PI, study recruitment, target enrollment, inclusion/exclusion criteria, informed 
 consent process, screening procedures/visit, randomization/baseline visit, amount 
 of personnel required  outside of study team, and follow-up visit procedures. This 
                                               
 53Lisa A.Speicher, , Gregg Fromell, Sue Avery, Donna Brassil, Lori Carlson, Erika Stevens, and Michele 
Toms. “The Critical Need for Academic Health Centers to Assess the Training, Support, and Career 
Development Requirements of Clinical Research Coordinators: Recommendations from the Clinical and 
Translational Science Award Research Coordinator Taskforce*.” Clinical and Translational Science 5, no. 
6 (2012): 470–475. Accessed November 11, 2019. http://doi.wiley.com/10.1111/j.1752-
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 tool can be customized to include other study elements, based the protocol, such 
 as data collection and site monitoring requirements, for example. 
  In the complexity tool shown below, after adding up all the study 
 elements, the highest possible score is 30. The PI can translate this score into 
 work effort projections when preparing the budget or assigning staff projects to 
 ensure equitable workloads. If a CRC has several protocols with high scores, this 
 should indicate the need for additional staff, the need to reassign trials and/or 
 reallocate staff. 
Table 3. Complexity Tool Example 
 
Source: Adapted from Alexa Richie, DHSc; Dale Gamble, MHSc; Andrea Tavlarides, PhD; Carol Griffin. 
“Trial Complexity and Coordinator Capacity: The Development of a Complexity Tool.” Clinical 






 4.2. Creative Staffing 
  The PI may have to look at other ways to off-load some of the work 
 burden when hiring an additional CRC is not option due to budget constraints. 
 Consider hiring a Research Assistant(s) to help with tasks such as, scheduling 
 study visits, request medical  records, abstract data, and administer 
 questionnaires. Another option is a Quality Assurance/Quality (QA/QC) person to 
 monitor the safety of participants, the accuracy of the data, informed consent 
 compliance, and adherence to protocol treatment, through the duration of the 
 clinical trial. 
 4.3. Cross-training 
  A critical component of any research program is cross coverage for 
 vacations and/or sick time. The CRC and/or the research staff should not feel 
 incapable of taking time off for fear that no one will be able to cover their work. 
 A backup should always be determined during the initial assignment of the 
 protocol. A back-up may be the PI, co-Investigator, sub-Investigator, another 
 CRC, or Research Assistant (RA). If the RA is the back-up coverage should be 








Chapter 5: Evaluation and Feedback 
 On the day of hire, and at the beginning of each year a formal review of 
performance expectations/ objectives should be discussed and agreed upon. The 
expectations should be based on the CRC’s job description. In addition to the job 
description, the PI should create a Performance Evaluation (PE) tool that aligns to the job 
description, using a template provided by the institution. The objectives on the PE tool 
should be clear, measurable, achievable, and relevant.  
 Following the discussion at the beginning of the year is the mid-year review, 
which allows the PI to look back over the last 6 months, assess whether or not the CRC is 
meeting expectations, make adjustments if needed, and/or provide more coaching. By the 
end of the year the CRC should know what to expect on the final evaluation. There 
should not be any surprises. 
 5.1. Performance Evaluation (PE) Tool 
 Examples of five basic performance objectives/milestones for a CRC: 
 1. Organizes research according to specific protocol guidelines  
• Study visits are conducted according to schedule of events 
• Visits are scheduled within the study window 
• Case Report Forms (CRFs) and/or data entry are completed on 
time 
• Data queries are answered within the required time frame 
• Source documentation is accurate and complete 
2. Effective planning and preparing for study visits in order to: 





• Maximize retention of research participants 
• Promote a positive experience during the research visit 
• Coordinate with other services (Pharmacy, Clinical Research 
Center, etc.) 
3. Human Subject Compliance  
• Participants are consented and re-consented according to GCP 
• Only eligible participants are enrolled into the study 
• Children under the age of 18 are assented according to Federal, 
local, and institutional guidelines 
• Consenting process and eligibility are adequately documented 
4. Adverse/Serious Adverse Events and Study Endpoints 
• Identify and report any detrimental medical occurrences 
• Report hospitalizations/prolongation of existing hospitalizations 
• Report any life-threatening events and/or deaths 
• Understand and identify study requirements for discontinuing study 
treatment and/or study follow-up 
5. Required Training 
• Remains up-to-date on regulatory compliance training  
• Institutional required training is up-to-date 
• License and/or certifications are renewed on time 
5.2. Feedback  
 In addition to the formal evaluation process, it is necessary to provide timely 
and thoughtful feedback. Any criticism should be done respectfully and in private. 
Addressing issues early helps to keep problems from becoming harder to manage. 
Waiting until there are multiple issues to address can overwhelm the CRC. Most 






Chapter 6: Effective Handover of Clinical Trials 
 A process for effectively handing over a clinical trial(s) should be in place before 
a CRC’s leave of absence (if possible), resignation, or retirement. This process will 
alleviate gaps in study procedures, deviations caused by noncompliance, and/or harm to 
the study participant. 
 6.1. Handing-Off Work Assignments 
  The CRC must ensure the research team has access to any study-related 
 files that are stored electronically and/or hard copies. She/he must also inform the 
 team of any files that were sent to an off-site storage facility. For long-term 
 studies (> 3yrs) the CRC should provide a list of key contacts such as study 
 affiliates who are in other departments, site monitors, sponsor project officers, and 
 any other personnel who are not on the study team. 
  All outstanding queries, delinquent forms, SAE/AEs that have not been 
 resolved, screening lists of study potentials, and an inventory of study supplies, 
 are examples of the kind of things the CRC should review with the team/person 
 taking over the study. The Investigational Pharmacy, Regulatory Coordinator, and 
 Lab Technician must all be notified of the CRCs departure and allowed to address 
 any outstanding concerns.  
 6.2. Research Participant Considerations 
  It is critical to consider the needs of the research participants in the hand-





 and may consider it a significant loss when they leave. The participant should be 
 notified by phone or in-person by the departing CRC, and when possible 
 introduced to the new CRC. Reassuring the participant that they will remain in 
 good hands may help to mitigate the  loss of continued study participation. 
  The departing CRC should review the study visit windows so the team 
 member(s) will know when the next visit is due and provide any tips/special 
 circumstances with the participants and family members. Support and sensitivity 
 must be provided to the CRC as this may be difficult for her/him as well. The 























Adverse Event (AE). Any untoward or unfavorable medical occurrence in a human 
subject, including any abnormal sign (for example, abnormal physical exam or laboratory 
finding), symptom, or disease, temporally associated with the subject’s participation in 
the research, whether or not considered related to the subject’s participation in the 
research.55 
 
Assent. A child’s affirmative agreement to participate in research. Mere failure to object 
should not, absent of affirmative agreement, be construed as assent. (45 CFR §46.402(b) 
and 21 CFR §50.3(n))56 
 
Belmont Report. Guidelines that identifies three basic ethical principles that address 
ethical issues arising from the conduct of biomedical and behavioral research involving 
human subject. The ethical principles include: Respect for Persons, Beneficence, and 
Justice.57 
 
Clinical Research. Research conducted on participants, material, or data of human origin 
with an identifiable person as the source. Clinical research includes exploratory, 
behavioral, and observational studies.58 
 
Good Clinical Practice. An international ethical and scientific quality standard for 
designing, conducting, recording, and reporting trials that involve the participation of 
human subjects. (ICH E6)59 
 
Informed Consent Process. A process by which a participant voluntarily confirms his or 
her willingness to participate in a particular study after having been informed of all 
aspects of the trial that are relevant to the participant’s decision to participate. (ICH E6)60  
 
                                               
 55 “NIH, National Institute of Allergy & Infectious Disease (NIAID).” Rules and Policies for Clinical 
Research. Last modified July 18, 2018. https://www.niaid.nih.gov/research/daids-clinical-research-
glossary#g. 
56 Ibid 
57 “Belmont Report.” U.S. Department of Health and Human Services (HHS), Office for Human Research 
Protections (OHRP). Last modified March 15, 2016. https://www.hhs.gov/ohrp/regulations-and-
policy/belmont-report/index.html. 







Investigational Review Board (IRB). The board, committee, or other group formally 
designated by an institution to review, to approve the initiation of, and to conduct 
periodic review of research involving human subjects. The primary purpose of such 
review is to assure the protection of the rights and welfare of participants in research. IRB 
reviewing DHHS sponsored research must be registered with OHRP and identified on the 
institute FWA.61 
 
Investigational New Drug (IND). A drug or biological product that is used in a clinical 
investigation. 
 
Legally Authorized Representative (LAR). An individual or judicial or other body 
authorized under applicable law to consent on behalf of a prospective subject to the 
subject’s participation in the procedure(s) involved in the research (45 CFR 46.102(c)). 
The issue as to who can be an LAR is determined by the laws of the jurisdiction in which 
the research is conducted (e.g., local or state law).62  
Participant. A living individual about whom an investigator conducting research 
obtains: 
(1) Data through intervention or interaction with the individual, or 
(2) Identifiable private information. (45 CFR 46). 
The terms “participant " and “subject” are deemed to be synonymous within NIH 
Division of AIDS policies. (DAIDS)63 
 
Principal Investigator (PI). The qualified person designated by the applicant institution 
to direct the funded research program. PIs oversee the scientific and technical aspects of 
an award and the day-to-day management of the research.64 
 
Protocol Deviation/Violation. An unplanned excursion from the protocol that is not 
implemented or intended as a systematic change. Protocol deviation is also used to refer 
to any other, unplanned instance(s) of protocol noncompliance. For example, situations in 
which the investigator failed to perform tests or examinations as required by the protocol 
                                               
61 Ibid 
 62 “45 CFR 46, Department of Health & Human Services (DHHS).” Office for Human Research 
Protections. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html. 






or failures on the part of study subjects to complete scheduled visits as required by the 
protocol, would be considered protocol deviations.65 
 
Serious Adverse Event (SAE). Any untoward medical occurrence that at any dose 
results in death, is life-threatening, requires inpatient hospitalization or prolongation of 
existing hospitalization, results in persistent or significant disability/incapacity, or is a 
congenital anomaly/birth defect. This includes important medical events that may not be 
immediately life-threatening or result in death or hospitalization but may jeopardize the 
patient or may require intervention to prevent one of the outcomes listed in the definition 



























ACRP  Association of Clinical Research Professionals 
AE  Adverse Event 
ALCOA Attributable, Legible, Contemporaneous, Original, Accurate 
BRAIN Biomedical Research and Assurance Information Network 
CCRP  Certified Clinical Research Professional 
CITI  Collaborative Institutional Training Initiative 
CoI  Conflict of Interest  
CRC  Clinical Research Coordinator 
CRF  Case Report Form 
CTMS  Clinical Trial Management System 
DDE  Direct Data Entry 
DoDL  Delegation of Duties Log 
EMR  Electronic Medical Record 
GCP  Good Clinical Practice 
HHS  Health and Human Services 
IAR  Immunology Allergy & Retrovirology 
IATA  International Air Transportation Association 
ICH  International Council on Harmonisation 
IFF  Interview Feedback Form 
IND  Investigational New Drug 
OES  Office of Environmental Safety 
OHRP  Office of Human Research Protections 
PI  Principal Investigator 
SAE  Serious Adverse Event 
RPPR  Research Performance Progress Report 
SEV  Site Establishment Visit 
SIV  Site Initiation Visit 
SoCRA Society of Clinical Research Associates 
STAR  Situation, Task, Action, Result 
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